APO Research
Talk to an analyst

APO RESEARCH · REPORT

Palonosetron

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Palonosetron Industry Growth and Trends Forecast to 2032

22 December 2025109 pages

Choose your research edition.

Industry ResearchPalonosetron Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Palonosetron Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Palonosetron Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Palonosetron Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Palonosetron Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Palonosetron market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Palonosetron is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Palonosetron is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Palonosetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Palonosetron include Teva, Sichuan Hairong Pharmaceutical, Qilu Pharmaceutical, Pfizer, Fresenius Kabi, Jiangsu Aosaikang Pharmaceutical, Sagent Pharmaceuticals, Helsinn Therapeutics and Exela Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Palonosetron market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Palonosetron market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Palonosetron market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Palonosetron.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Palonosetron market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Palonosetron Market by Company

Teva

Sichuan Hairong Pharmaceutical

Qilu Pharmaceutical

Pfizer

Fresenius Kabi

Jiangsu Aosaikang Pharmaceutical

Sagent Pharmaceuticals

Helsinn Therapeutics

Exela Pharma

Dr. Reddys Laboratories

Cipla

Palonosetron Segment by Type

Injection 0.25 mg/5 mL

Injection 20 mcg/kg (max 1.5 mg)

Palonosetron Segment by Application

Adults

Children

Palonosetron Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Palonosetron market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Palonosetron and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Palonosetron.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Palonosetron manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Palonosetron in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection 0.25 mg/5 mL Table 2. Major Company of Injection 20 mcg/kg (max 1.5 mg) Table 3. Global Palonosetron Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Palonosetron Sales by Type (2021-2026) & (k units) Table 5. Global Palonosetron Sales Market Share in Volume by Type (2021-2026) Table 6. Global Palonosetron Sales by Type (2021-2026) & (US$ Million) Table 7. Global Palonosetron Sales Market Share in Value by Type (2021-2026) Table 8. Global Palonosetron Price by Type (2021-2026) & (US$/unit) Table 9. Global Palonosetron Sales by Type (2027-2032) & (k units) Table 10. Global Palonosetron Sales Market Share in Volume by Type (2027-2032) Table 11. Global Palonosetron Sales by Type (2027-2032) & (US$ Million) Table 12. Global Palonosetron Sales Market Share in Value by Type (2027-2032) Table 13. Global Palonosetron Price by Type (2027-2032) & (US$/unit) Table 14. North America Palonosetron Sales by Type (2021-2026) & (k units) Table 15. North America Palonosetron Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Palonosetron Sales by Type (2021-2026) & (k units) Table 17. Europe Palonosetron Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Palonosetron Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Palonosetron Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Palonosetron Sales by Type (2021-2026) & (k units) Table 21. Latin America Palonosetron Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Palonosetron Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Palonosetron Sales by Type (2021-2026) & (US$ Million) Table 24. Palonosetron Industry Trends Table 25. Palonosetron Industry Drivers Table 26. Palonosetron Industry Opportunities and Challenges Table 27. Palonosetron Industry Restraints Table 28. Global Palonosetron Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Palonosetron Revenue Market Share by Company (2021-2026) Table 30. Global Palonosetron Sales by Company (2021-2026) & (k units) Table 31. Global Palonosetron Sales Share by Company (2021-2026) Table 32. Global Palonosetron Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Palonosetron Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Palonosetron Major Company Production Sites and Headquarters Table 35. Global Palonosetron Company, Product Type & Application Table 36. Global Palonosetron Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Palonosetron by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Palonosetron Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Palonosetron Sales by Region (2021-2026) & (k units) Table 41. Global Palonosetron Sales Market Share in Volume by Region (2021-2026) Table 42. Global Palonosetron Sales by Region (2021-2026) & (US$ Million) Table 43. Global Palonosetron Sales Market Share in Value by Region (2021-2026) Table 44. Global Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Palonosetron Sales by Region (2027-2032) & (k units) Table 46. Global Palonosetron Sales Market Share in Volume by Region (2027-2032) Table 47. Global Palonosetron Sales by Region (2027-2032) & (US$ Million) Table 48. Global Palonosetron Sales Market Share in Value by Region (2027-2032) Table 49. Global Palonosetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Palonosetron Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Palonosetron Sales by Application (2021-2026) & (k units) Table 52. Global Palonosetron Sales Market Share in Volume by Application (2021-2026) Table 53. Global Palonosetron Sales by Application (2021-2026) & (US$ Million) Table 54. Global Palonosetron Sales Market Share in Value by Application (2021-2026) Table 55. Global Palonosetron Price by Application (2021-2026) & (US$/unit) Table 56. Global Palonosetron Sales by Application (2027-2032) & (k units) Table 57. Global Palonosetron Sales Market Share in Volume by Application (2027-2032) Table 58. Global Palonosetron Sales by Application (2027-2032) & (US$ Million) Table 59. Global Palonosetron Sales Market Share in Value by Application (2027-2032) Table 60. Global Palonosetron Price by Application (2027-2032) & (US$/unit) Table 61. North America Palonosetron Sales by Application (2021-2026) & (k units) Table 62. North America Palonosetron Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Palonosetron Sales by Application (2021-2026) & (k units) Table 64. Europe Palonosetron Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Palonosetron Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Palonosetron Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Palonosetron Sales by Application (2021-2026) & (k units) Table 68. Latin America Palonosetron Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Palonosetron Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Palonosetron Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Palonosetron Product Portfolio Table 75. Teva Recent Development Table 76. Sichuan Hairong Pharmaceutical Company Information Table 77. Sichuan Hairong Pharmaceutical Business Overview Table 78. Sichuan Hairong Pharmaceutical Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sichuan Hairong Pharmaceutical Palonosetron Product Portfolio Table 80. Sichuan Hairong Pharmaceutical Recent Development Table 81. Qilu Pharmaceutical Company Information Table 82. Qilu Pharmaceutical Business Overview Table 83. Qilu Pharmaceutical Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Qilu Pharmaceutical Palonosetron Product Portfolio Table 85. Qilu Pharmaceutical Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Pfizer Palonosetron Product Portfolio Table 90. Pfizer Recent Development Table 91. Fresenius Kabi Company Information Table 92. Fresenius Kabi Business Overview Table 93. Fresenius Kabi Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Fresenius Kabi Palonosetron Product Portfolio Table 95. Fresenius Kabi Recent Development Table 96. Jiangsu Aosaikang Pharmaceutical Company Information Table 97. Jiangsu Aosaikang Pharmaceutical Business Overview Table 98. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolio Table 100. Jiangsu Aosaikang Pharmaceutical Recent Development Table 101. Sagent Pharmaceuticals Company Information Table 102. Sagent Pharmaceuticals Business Overview Table 103. Sagent Pharmaceuticals Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Sagent Pharmaceuticals Palonosetron Product Portfolio Table 105. Sagent Pharmaceuticals Recent Development Table 106. Helsinn Therapeutics Company Information Table 107. Helsinn Therapeutics Business Overview Table 108. Helsinn Therapeutics Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Helsinn Therapeutics Palonosetron Product Portfolio Table 110. Helsinn Therapeutics Recent Development Table 111. Exela Pharma Company Information Table 112. Exela Pharma Business Overview Table 113. Exela Pharma Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Exela Pharma Palonosetron Product Portfolio Table 115. Exela Pharma Recent Development Table 116. Dr. Reddys Laboratories Company Information Table 117. Dr. Reddys Laboratories Business Overview Table 118. Dr. Reddys Laboratories Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Dr. Reddys Laboratories Palonosetron Product Portfolio Table 120. Dr. Reddys Laboratories Recent Development Table 121. Cipla Company Information Table 122. Cipla Business Overview Table 123. Cipla Palonosetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Cipla Palonosetron Product Portfolio Table 125. Cipla Recent Development Table 126. North America Palonosetron Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. North America Palonosetron Sales by Country (2021-2026) & (k units) Table 128. North America Palonosetron Sales Market Share by Country (2021-2026) Table 129. North America Palonosetron Sales Forecast by Country (2027-2032) & (k units) Table 130. North America Palonosetron Sales Market Share Forecast by Country (2027-2032) Table 131. North America Palonosetron Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Palonosetron Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Palonosetron Market Share by Country (2021-2026) Table 134. North America Palonosetron Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Palonosetron Market Share Forecast by Country (2027-2032) Table 136. Europe Palonosetron Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Europe Palonosetron Sales by Country (2021-2026) & (k units) Table 138. Europe Palonosetron Sales Market Share by Country (2021-2026) Table 139. Europe Palonosetron Sales Forecast by Country (2027-2032) & (k units) Table 140. Europe Palonosetron Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Palonosetron Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Palonosetron Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Palonosetron Market Share by Country (2021-2026) Table 144. Europe Palonosetron Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Palonosetron Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Palonosetron Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Palonosetron Sales by Country (2021-2026) & (k units) Table 148. Asia-Pacific Palonosetron Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Palonosetron Sales Forecast by Country (2027-2032) & (k units) Table 150. Asia-Pacific Palonosetron Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Palonosetron Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Palonosetron Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Palonosetron Market Share by Country (2021-2026) Table 154. Asia-Pacific Palonosetron Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Palonosetron Market Share Forecast by Country (2027-2032) Table 156. Latin America Palonosetron Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Latin America Palonosetron Sales by Country (2021-2026) & (k units) Table 158. Latin America Palonosetron Sales Market Share by Country (2021-2026) Table 159. Latin America Palonosetron Sales Forecast by Country (2027-2032) & (k units) Table 160. Latin America Palonosetron Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Palonosetron Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Palonosetron Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Palonosetron Market Share by Country (2021-2026) Table 164. Latin America Palonosetron Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Palonosetron Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Palonosetron Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Palonosetron Sales by Country (2021-2026) & (k units) Table 168. Middle East and Africa Palonosetron Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Palonosetron Sales Forecast by Country (2027-2032) & (k units) Table 170. Middle East and Africa Palonosetron Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Palonosetron Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Palonosetron Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Palonosetron Market Share by Country (2021-2026) Table 174. Middle East and Africa Palonosetron Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Palonosetron Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Palonosetron Distributors List Table 179. Palonosetron Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Palonosetron Image Figure 2. Global Palonosetron Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Palonosetron Market Size (2021-2032) & (US$ Million) Figure 4. Global Palonosetron Sales (2021-2032) & (k units) Figure 5. Injection 0.25 mg/5 mL Image Figure 6. Global Injection 0.25 mg/5 mL Sales YoY Growth (2021-2032) & (k units) Figure 7. Injection 20 mcg/kg (max 1.5 mg) Image Figure 8. Global Injection 20 mcg/kg (max 1.5 mg) Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Palonosetron Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Palonosetron Market Share by Type 2025 VS 2032 Figure 11. North America Palonosetron Sales Market Share in Volume by Type in 2025 Figure 12. North America Palonosetron Sales Market Share in Value by Type in 2025 Figure 13. Europe Palonosetron Sales Market Share in Volume by Type in 2025 Figure 14. Europe Palonosetron Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Palonosetron Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Palonosetron Sales Market Share in Value by Type in 2025 Figure 17. Latin America Palonosetron Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Palonosetron Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Palonosetron Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Palonosetron Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Palonosetron Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adults Image Figure 24. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 25. Children Image Figure 26. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Palonosetron Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Palonosetron Market Share by Application 2025 VS 2032 Figure 29. North America Palonosetron Sales Market Share in Volume by Application in 2025 Figure 30. North America Palonosetron Sales Market Share in Value by Application in 2025 Figure 31. Europe Palonosetron Sales Market Share in Volume by Application in 2025 Figure 32. Europe Palonosetron Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Palonosetron Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Palonosetron Sales Market Share in Value by Application in 2025 Figure 35. Latin America Palonosetron Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Palonosetron Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Palonosetron Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Palonosetron Sales Market Share in Value by Application in 2025 Figure 39. North America Palonosetron Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Palonosetron Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Palonosetron Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Palonosetron Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Palonosetron Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Palonosetron Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Palonosetron Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Palonosetron Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Palonosetron Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Palonosetron Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Palonosetron Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Palonosetron Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Palonosetron Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Palonosetron Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Palonosetron Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Palonosetron Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Palonosetron Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Palonosetron Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Palonosetron Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Palonosetron Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Palonosetron Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Palonosetron Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Injection 0.25 mg/5 mL
  • Injection 20 mcg/kg (max 1.5 mg)
Applications
  • Adults
  • Children
Companies covered
  • Teva
  • Sichuan Hairong Pharmaceutical
  • Qilu Pharmaceutical
  • Pfizer
  • Fresenius Kabi
  • Jiangsu Aosaikang Pharmaceutical
  • Sagent Pharmaceuticals
  • Helsinn Therapeutics
  • Exela Pharma
  • Dr. Reddys Laboratories
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Palonosetron Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Palonosetron Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Palonosetron Market by Type
  6. 1.3.1 Injection 0.25 mg/5 mL
  7. 1.3.2 Injection 20 mcg/kg (max 1.5 mg)
  8. 1.4 Global Palonosetron Market Size by Type
  9. 1.4.1 Global Palonosetron Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Palonosetron Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Palonosetron Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Palonosetron Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Palonosetron Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Palonosetron Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Palonosetron Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Palonosetron Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Palonosetron Industry Trends
  2. 2.2 Palonosetron Industry Drivers
  3. 2.3 Palonosetron Industry Opportunities and Challenges
  4. 2.4 Palonosetron Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Palonosetron Revenue (2021-2026)
  2. 3.2 Global Top Players by Palonosetron Sales (2021-2026)
  3. 3.3 Global Top Players by Palonosetron Price (2021-2026)
  4. 3.4 Global Palonosetron Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Palonosetron Major Company Production Sites & Headquarters
  6. 3.6 Global Palonosetron Company, Product Type & Application
  7. 3.7 Global Palonosetron Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Palonosetron Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Palonosetron Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Palonosetron Tier 1, Tier 2, and Tier 3
4 Palonosetron Regional Status and Outlook
  1. 4.1 Global Palonosetron Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Palonosetron Historic Market Size by Region
  3. 4.2.1 Global Palonosetron Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Palonosetron Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Palonosetron Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Palonosetron Forecasted Market Size by Region
  7. 4.3.1 Global Palonosetron Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Palonosetron Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Palonosetron Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Palonosetron by Application
  1. 5.1 Palonosetron Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Palonosetron Market Size by Application
  5. 5.2.1 Global Palonosetron Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Palonosetron Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Palonosetron Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Palonosetron Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Palonosetron Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Palonosetron Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Palonosetron Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Palonosetron Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Palonosetron Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sichuan Hairong Pharmaceutical
  8. 6.2.1 Sichuan Hairong Pharmaceutical Company Information
  9. 6.2.2 Sichuan Hairong Pharmaceutical Business Overview
  10. 6.2.3 Sichuan Hairong Pharmaceutical Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Hairong Pharmaceutical Palonosetron Product Portfolio
  12. 6.2.5 Sichuan Hairong Pharmaceutical Recent Developments
  13. 6.3 Qilu Pharmaceutical
  14. 6.3.1 Qilu Pharmaceutical Company Information
  15. 6.3.2 Qilu Pharmaceutical Business Overview
  16. 6.3.3 Qilu Pharmaceutical Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Pharmaceutical Palonosetron Product Portfolio
  18. 6.3.5 Qilu Pharmaceutical Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Palonosetron Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Fresenius Kabi
  26. 6.5.1 Fresenius Kabi Company Information
  27. 6.5.2 Fresenius Kabi Business Overview
  28. 6.5.3 Fresenius Kabi Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fresenius Kabi Palonosetron Product Portfolio
  30. 6.5.5 Fresenius Kabi Recent Developments
  31. 6.6 Jiangsu Aosaikang Pharmaceutical
  32. 6.6.1 Jiangsu Aosaikang Pharmaceutical Company Information
  33. 6.6.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  34. 6.6.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolio
  36. 6.6.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  37. 6.7 Sagent Pharmaceuticals
  38. 6.7.1 Sagent Pharmaceuticals Company Information
  39. 6.7.2 Sagent Pharmaceuticals Business Overview
  40. 6.7.3 Sagent Pharmaceuticals Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sagent Pharmaceuticals Palonosetron Product Portfolio
  42. 6.7.5 Sagent Pharmaceuticals Recent Developments
  43. 6.8 Helsinn Therapeutics
  44. 6.8.1 Helsinn Therapeutics Company Information
  45. 6.8.2 Helsinn Therapeutics Business Overview
  46. 6.8.3 Helsinn Therapeutics Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Helsinn Therapeutics Palonosetron Product Portfolio
  48. 6.8.5 Helsinn Therapeutics Recent Developments
  49. 6.9 Exela Pharma
  50. 6.9.1 Exela Pharma Company Information
  51. 6.9.2 Exela Pharma Business Overview
  52. 6.9.3 Exela Pharma Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Exela Pharma Palonosetron Product Portfolio
  54. 6.9.5 Exela Pharma Recent Developments
  55. 6.10 Dr. Reddys Laboratories
  56. 6.10.1 Dr. Reddys Laboratories Company Information
  57. 6.10.2 Dr. Reddys Laboratories Business Overview
  58. 6.10.3 Dr. Reddys Laboratories Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Dr. Reddys Laboratories Palonosetron Product Portfolio
  60. 6.10.5 Dr. Reddys Laboratories Recent Developments
  61. 6.11 Cipla
  62. 6.11.1 Cipla Company Information
  63. 6.11.2 Cipla Business Overview
  64. 6.11.3 Cipla Palonosetron Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cipla Palonosetron Product Portfolio
  66. 6.11.5 Cipla Recent Developments
7 North America by Country
  1. 7.1 North America Palonosetron Sales by Country
  2. 7.1.1 North America Palonosetron Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Palonosetron Sales by Country (2021-2026)
  4. 7.1.3 North America Palonosetron Sales Forecast by Country (2027-2032)
  5. 7.2 North America Palonosetron Market Size by Country
  6. 7.2.1 North America Palonosetron Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Palonosetron Market Size by Country (2021-2026)
  8. 7.2.3 North America Palonosetron Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Palonosetron Sales by Country
  2. 8.1.1 Europe Palonosetron Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Palonosetron Sales by Country (2021-2026)
  4. 8.1.3 Europe Palonosetron Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Palonosetron Market Size by Country
  6. 8.2.1 Europe Palonosetron Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Palonosetron Market Size by Country (2021-2026)
  8. 8.2.3 Europe Palonosetron Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Palonosetron Sales by Country
  2. 9.1.1 Asia-Pacific Palonosetron Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Palonosetron Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Palonosetron Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Palonosetron Market Size by Country
  6. 9.2.1 Asia-Pacific Palonosetron Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Palonosetron Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Palonosetron Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Palonosetron Sales by Country
  2. 10.1.1 South America Palonosetron Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Palonosetron Sales by Country (2021-2026)
  4. 10.1.3 South America Palonosetron Sales Forecast by Country (2027-2032)
  5. 10.2 South America Palonosetron Market Size by Country
  6. 10.2.1 South America Palonosetron Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Palonosetron Market Size by Country (2021-2026)
  8. 10.2.3 South America Palonosetron Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Palonosetron Sales by Country
  2. 11.1.1 Middle East and Africa Palonosetron Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Palonosetron Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Palonosetron Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Palonosetron Market Size by Country
  6. 11.2.1 Middle East and Africa Palonosetron Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Palonosetron Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Palonosetron Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Palonosetron Value Chain Analysis
  2. 12.1.1 Palonosetron Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Palonosetron Production Mode & Process
  7. 12.2 Palonosetron Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Palonosetron Distributors
  10. 12.2.3 Palonosetron Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst